Skye Bioscience, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $167.35 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2014-11-14
- Skye Bioscience, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-07-31 was -$7.94K, a 1088.06% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-04-30 was $1.20K, a 80.53% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-01-31 was -$2.29K, a 277.92% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-10-31 was $2.50K, a 33.91% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $10.75K, a 148.65% increase from fiscal 2012.
- Skye Bioscience, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $4.33K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 25 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 29 month |
|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $167.35K 10-Q · filed 2014-11-14 | |||||||
| 2014-07-31 | -$7.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | -$6.74K derived: sum of 2 quarters · filed 2014-09-15 | -$9.03K 10-Q · filed 2014-09-15 | -$6.54K derived: sum of 4 quarters · filed 2014-09-15 | ||||
| 2014-04-30 | $1.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | -$1.09K 10-Q · filed 2014-06-05 | $1.41K derived: sum of 3 quarters · filed 2014-06-05 | $2.21K derived: sum of 4 quarters · filed 2014-09-15 | ||||
| 2014-01-31 | -$2.29K 10-Q · filed 2014-03-17 | $207.00 derived: sum of 2 quarters · filed 2014-03-17 | $1.01K derived: sum of 3 quarters · filed 2014-09-15 | $7.18K derived: sum of 4 quarters · filed 2014-09-15 | ||||
| 2013-10-31 | $2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $3.30K derived: sum of 2 quarters · filed 2014-09-15 | $9.47K derived: sum of 3 quarters · filed 2014-09-15 | $10.75K 10-K · filed 2014-01-27 | ||||
| 2013-09-30 | $90.30K 10-Q · filed 2014-11-14 | |||||||
| 2013-07-31 | $804.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $6.97K derived: sum of 2 quarters · filed 2014-09-15 | $8.26K 10-Q · filed 2014-09-15 | $7.05K 10-Q · filed 2013-09-16 | $12.03K derived: sum of 4 quarters · filed 2014-09-15 | $11.13K 10-Q · filed 2013-09-16 | ||
| 2013-04-30 | $6.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $7.46K 10-Q · filed 2014-06-05 | $6.32K 10-Q · filed 2013-06-27 | $11.23K derived: sum of 3 quarters · filed 2014-06-05 | $11.23K derived: sum of 4 quarters · filed 2014-06-05 | $10.40K 10-Q · filed 2013-06-27 | ||
| 2013-01-31 | $1.29K 10-Q · filed 2014-03-17 | $5.06K derived: sum of 2 quarters · filed 2014-03-17 | $5.06K derived: sum of 3 quarters · filed 2014-03-17 | |||||
| 2012-10-31 | $3.77K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $3.77K derived: sum of 2 quarters · filed 2014-01-27 | $4.33K 10-K · filed 2014-01-27 | |||||
| 2012-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-16 | $550.00 10-Q · filed 2013-09-16 | ||||||
| 2012-04-30 | $550.00 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |